Novo Nordisk A/S | NOVOB - Loan Capital

Stock Price
295.25
Daily Change
14.55 5.18%
Monthly
-18.90%
Yearly
-53.50%
Q1 Forecast
351.07

Novo Nordisk reported DKK118.94B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Bausch Health Companies USD 20.46B 396M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Novo Nordisk DKK 118.94B 29.76B Dec/2025
Novo Nordisk DKK 14.02B 224.49M Sep/2025
Pacira USD 376.72M 1.37M Sep/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022